362 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
ABT Abbott Laboratories $67.67 $118.71B N/A
Article Searches
Globus Medical (GMED) Q1 Earnings Miss, Revenues Grow Y/Y (Revised) http://www.zacks.com/stock/news/408904/globus-medical-gmed-q1-earnings-miss-revenues-grow-y-y-revised?cid=CS-ZC-FT-408904 May 06, 2019 - Globus Medical (GMED) management states that the first quarter of a year poses a seasonal challenge to the company's capital equipment, which grossly affects its sales in Q1.
Medidata (MDSO) Q1 Earnings Beat Estimates, Margins fall http://www.zacks.com/stock/news/408371/medidata-mdso-q1-earnings-beat-estimates-margins-fall?cid=CS-ZC-FT-408371 May 03, 2019 - Medidata (MDSO) witnesses year-over-year revenue growth in double-digits across both operating segments in first-quarter 2019.
PRA Health (PRAH) Q1 Earnings Beat Estimates, Revenues Miss http://www.zacks.com/stock/news/408357/pra-health-prah-q1-earnings-beat-estimates-revenues-miss?cid=CS-ZC-FT-408357 May 03, 2019 - PRA Health's (PRAH) Q1 earnings reflect top-line growth, favorable segmental performance and margin expansion.
ResMed's (RMD) Q3 Earnings Beat Estimates, Revenues in Line http://www.zacks.com/stock/news/408323/resmeds-rmd-q3-earnings-beat-estimates-revenues-in-line?cid=CS-ZC-FT-408323 May 03, 2019 - ResMed (RMD) registers double-digit global revenue growth in Q3 on the back of solid sales from Software-as-a-Service businesses and new mask products plus devices.
ABBOTT LABORATORIES (ABT) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/05/02/abbott-laboratories-abt-q1-2019-earnings-call-tran.aspx?source=iedfolrf0000001 May 02, 2019 - ABT earnings call for the period ending March 31, 2019.
Amedisys (AMED) Tops Earnings and Revenue Estimates in Q1 http://www.zacks.com/stock/news/407597/amedisys-amed-tops-earnings-and-revenue-estimates-in-q1?cid=CS-ZC-FT-407597 May 02, 2019 - At Home Health and Hospice divisions, Amedisys (AMED) witnesses solid year-over-year growth in Medicare and non-Medicare revenues.
ABIOMED (ABMD) Q4 Earnings Meet Estimates, Sales Rise in Japan http://www.zacks.com/stock/news/407593/abiomed-abmd-q4-earnings-meet-estimates-sales-rise-in-japan?cid=CS-ZC-FT-407593 May 02, 2019 - ABIOMED's (ABMD) Q4 results gain from solid Impella show in Japan.
Hologic's (HOLX) Q2 Earnings Beat Estimates, Margins Fall http://www.zacks.com/stock/news/407589/hologics-holx-q2-earnings-beat-estimates-margins-fall?cid=CS-ZC-FT-407589 May 02, 2019 - Hologic (HOLX) registers solid Q1year-over-year revenue growth in core businesses like Breast Health and Molecular Diagnostics.
CVS Health's (CVS) Q1 Earnings Top Estimates, EPS View Up http://www.zacks.com/stock/news/406787/cvs-healths-cvs-q1-earnings-top-estimates-eps-view-up?cid=CS-ZC-FT-406787 May 01, 2019 - Year-over-year growth in CVS Health's (CVS) top line is aided by a strong Pharmacy Services segment, benefiting from the upside in specialty services.
Tandem's (TNDM) Q1 Loss Wider Than Expected, Sales Top Mark http://www.zacks.com/stock/news/406770/tandems-tndm-q1-loss-wider-than-expected-sales-top-mark?cid=CS-ZC-FT-406770 May 01, 2019 - Tandem's (TNDM) introduction of t:slim X2 with Basal-IQ technology, ramped-up supply capacity along with its global launch, substantially drive its top line in Q1.

Pages: 123456789...37

<<<Page 4>